Akumin (NASDAQ:AKU) Upgraded to “Hold” by Zacks Investment Research

Share on StockTwits

Zacks Investment Research upgraded shares of Akumin (NASDAQ:AKU) from a sell rating to a hold rating in a research note issued to investors on Wednesday morning, Zacks.com reports.

According to Zacks, “Akumin Inc. is a provider of freestanding, fixed-site outpatient diagnostic imaging services principally in the United States. The company’s imaging procedures include MRI, CT, positron emission tomography, ultrasound, diagnostic radiology, mammography and other interventional procedures. Akumin Inc. is based in PLANTATION, Fla. “

Shares of AKU stock traded up $0.01 during trading hours on Wednesday, reaching $3.01. The company had a trading volume of 62,011 shares, compared to its average volume of 46,001. Akumin has a twelve month low of $1.25 and a twelve month high of $3.78. The company’s fifty day simple moving average is $3.10.

Akumin Company Profile

Akumin Inc provides outpatient diagnostic imaging services in the United States. As of December 31, 2019, the company operated 129 imaging centers located in Florida, Pennsylvania, Delaware, Georgia, Texas, Illinois, and Kansas. Its centers offer physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders, and reduce unnecessary invasive procedures.

See Also: How to Use the MarketBeat Retirement Calculator

Get a free copy of the Zacks research report on Akumin (AKU)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Akumin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akumin and related companies with MarketBeat.com's FREE daily email newsletter.